CD29 marks superior cytotoxic human T cells
Citations Over Time
Abstract
ABSTRACT Cytotoxic CD8 + T cells can effectively kill target cells by producing cytokines, chemokines and granzymes. Expression of these effector molecules is however highly divergent, and tools that identify and pre-select potent killer cells are lacking. Human CD8 + T cells can be divided into IFN-γ and IL-2 producing cells. Unbiased RNA-sequencing and proteomics analysis on cytokine-producing fixed cells revealed that IL-2 + T cells produce helper cytokines, and that IFN-γ + T cells produce cytotoxic molecules. IFN-γ + T cells could be identified with the surface marker CD29 already prior to stimulation. CD29 also marked T cells with cytotoxic gene expression from different tissues in single-cell RNA-sequencing data. Notably, the cytotoxic features of CD29 + T cells were maintained during cell culture, suggesting a stable phenotype. Pre-selecting CD29-expressing MART1 TCR-engineered T cells potentiated the killing of target cells. We therefore propose that selecting for CD29 + T cells could boost the anti-tumoral activity of T cell therapeutics.
Related Papers
- → Cytotoxic T lymphocyte–induced killing in the absence of granzymes A and B is unique and distinct from both apoptosis and perforin-dependent lysis(2006)91 cited
- → Cutting Edge: Granzymes A and B Are Not Essential for Perforin-Mediated Tumor Rejection(2003)96 cited
- → Perforin and granzymes in neurological infections: From humans to cattle(2021)3 cited
- → Perforin and granzyme mediated toxicity on cultured oligodendrocytes(2002)
- → Investigation of perforin pore function and formation(2017)